InMed Pharmaceuticals Inc. (INM) Balance Sheet Analysis - Assets, Liabilities & Financial Position - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    InMed Pharmaceuticals Inc...

    NASDAQ: INM · Real-Time Price · USD
    2.29
    0.03 (1.33%)
    At close: Oct 03, 2025, 3:59 PM
    2.24
    -2.18%
    After-hours: Oct 03, 2025, 06:47 PM EDT

    InMed Pharmaceuticals Balance Sheet Statement

    Financials in USD. Fiscal year is July - June.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2025 FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Jun 30, 2025 Jun 30, 2024 Jun 30, 2023 Jun 30, 2022 Jun 30, 2021
    Cash & Equivalents
    		 11.12M 8.99M 11.81M 7.95M 9.11M
    Short-Term Investments
    		 43.56K n/a n/a n/a 57.46K
    Long-Term Investments
    		 n/a n/a n/a n/a n/a
    Other Long-Term Assets
    		 100.42K 136.76K 138.98K 227.43K 18.12K
    Receivables
    		 467.05K 482.55K 344.97K 113.34K 14.74K
    Inventory
    		 965.2K 1.7M 2.14M 3.21M n/a
    Other Current Assets
    		 323.09K 712.28K 718.62K 57.69K n/a
    Total Current Assets
    		 12.92M 11.88M 15.01M 12.36M 10.36M
    Property-Plant & Equipment
    		 996.35K 1.71M 958.37K 1.16M 403.91K
    Goodwill & Intangibles
    		 1.63M 2.44M 2.58M 2.72M 1.31M
    Total Long-Term Assets
    		 2.72M 4.29M 3.68M 4.11M 1.74M
    Total Assets
    		 15.65M 16.17M 18.69M 16.46M 12.1M
    Account Payables
    		 371.69K 856.4K 720.91K 1.5M 958.63K
    Deferred Revenue
    		 n/a n/a n/a n/a n/a
    Short-Term Debt
    		 n/a n/a n/a n/a n/a
    Other Current Liabilities
    		 546.01K 667.78K 739.85K 179.13K 1.09M
    Total Current Liabilities
    		 1.85M 2.7M 2.65M 4.27M 2.74M
    Long-Term Debt
    		 n/a n/a n/a n/a n/a
    Other Long-Term Liabilities
    		 n/a n/a n/a n/a n/a
    Total Long-Term Liabilities
    		 307.03K 881.94K 21.19K 501.51K 234.1K
    Total Liabilities
    		 2.15M 3.58M 2.67M 4.78M 2.97M
    Total Debt
    		 744.37K 1.32M 518.92K 1.02M 333.64K
    Book Value
    		 13.49M 12.59M 16.02M 11.69M 9.12M
    Book Value Per Share
    		 13.82 16.52 65.49 208.46 339.40
    Common Stock
    		 91.6M 113.22M 102.83M 91.06M 74.93M
    Retained Earnings
    		 -117.73M -149.18M -134.33M -120.33M -92.57M
    Comprehensive Income
    		 129.11K 175.83K 170.32K 165.54K 159.01K
    Shareholders Equity
    		 13.49M 12.59M 16.02M 11.69M 9.12M
    Total Investments
    		 43.56K n/a n/a n/a 57.46K

    Add to Watchlist